- Home
- FDMT vs BOC Comparison
FDMT vs BOC Comparison
Compare FDMT & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | BOC |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 392.9M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FDMT | BOC |
|---|---|---|
| Price | $7.21 | $12.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $30.33 | $25.00 |
| AVG Volume (30 Days) | ★ 1.2M | 184.9K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $120,000.00 | ★ $112,601,970.00 |
| Revenue This Year | $21,181.08 | $6.06 |
| Revenue Next Year | $162.43 | $4.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 605.88 | 7.22 |
| 52 Week Low | $2.24 | $11.30 |
| 52 Week High | $12.34 | $15.75 |
Technical Indicators
Market Signals| Indicator | FDMT | BOC |
|---|---|---|
| Relative Strength Index (RSI) | 29.73 | 49.68 |
| Support Level | $6.96 | $12.20 |
| Resistance Level | $11.81 | $12.92 |
| Average True Range (ATR) | 0.68 | 0.34 |
| MACD | -0.18 | -0.04 |
| Stochastic Oscillator | 4.95 | 35.56 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About BOC Boston Omaha Corporation
Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.